Gregory J. Divis has been appointed chief executive officer, Avadel Pharmaceuticals plc. Mr. Divis has served in the role on an interim basis since January 2019.   Mr. Divis joined the company as chief commercial officer in January 2017. He was promoted to chief operating officer in March 2018. Prior to joining Avadel, he served as an executive in Residence at Linden Capital Partners, a healthcare-focused private equity firm. From 2010 to 2014, he was president and chief executive officer of ...